Ofrat Beyar‐Katz

1.2k total citations
41 papers, 755 citations indexed

About

Ofrat Beyar‐Katz is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Ofrat Beyar‐Katz has authored 41 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 12 papers in Hematology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Ofrat Beyar‐Katz's work include CAR-T cell therapy research (19 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (5 papers). Ofrat Beyar‐Katz is often cited by papers focused on CAR-T cell therapy research (19 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (5 papers). Ofrat Beyar‐Katz collaborates with scholars based in Israel, United States and Canada. Ofrat Beyar‐Katz's co-authors include Yuval Shaked, Saar Gill, Irit Avivi, Michael Timaner, Chava Perry, Yael Bar‐On, Ron Ram, Odelia Amit, Noam Benyamini and Gabi Shefer and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ofrat Beyar‐Katz

38 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ofrat Beyar‐Katz Israel	15	444	180	179	166	136	41	755
Joseph Alvarnas United States	12	342 0.8×	86 0.5×	144 0.8×	270 1.6×	174 1.3×	31	880
Usama Gergis United States	18	427 1.0×	128 0.7×	141 0.8×	198 1.2×	538 4.0×	112	975
Nausheen Ahmed United States	16	666 1.5×	144 0.8×	146 0.8×	222 1.3×	257 1.9×	150	1.0k
Hisham Abdel‐Azim United States	17	275 0.6×	61 0.3×	277 1.5×	294 1.8×	277 2.0×	68	966
Reuben Benjamin United Kingdom	19	498 1.1×	134 0.7×	295 1.6×	374 2.3×	168 1.2×	43	1.1k
Solveig G. Ericson United States	20	883 2.0×	84 0.5×	182 1.0×	227 1.4×	284 2.1×	67	1.4k
Jonas S. Heitmann Germany	14	303 0.7×	112 0.6×	314 1.8×	201 1.2×	98 0.7×	71	638
Kathleen Dorritie United States	15	466 1.0×	46 0.3×	216 1.2×	166 1.0×	179 1.3×	45	773
Erden Atilla Türkiye	14	505 1.1×	64 0.4×	200 1.1×	183 1.1×	289 2.1×	61	876
Béatrice Clemenceau France	21	449 1.0×	76 0.4×	590 3.3×	233 1.4×	125 0.9×	50	1.2k

Countries citing papers authored by Ofrat Beyar‐Katz

Since Specialization

Citations

This map shows the geographic impact of Ofrat Beyar‐Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofrat Beyar‐Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofrat Beyar‐Katz more than expected).

Fields of papers citing papers by Ofrat Beyar‐Katz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofrat Beyar‐Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofrat Beyar‐Katz. The network helps show where Ofrat Beyar‐Katz may publish in the future.

Co-authorship network of co-authors of Ofrat Beyar‐Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Ofrat Beyar‐Katz. A scholar is included among the top collaborators of Ofrat Beyar‐Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofrat Beyar‐Katz. Ofrat Beyar‐Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rozenberg, Ayal, Shahar Shelly, Riva Fineman, et al.. (2025). CCR5 predicts neurotoxicity in CAR‐T‐cell therapy. British Journal of Haematology. 207(3). 1133–1137. 1 indexed citations

Ram, Ron, Odelia Amit, Amos Adler, et al.. (2023). Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial. Transplantation and Cellular Therapy. 29(11). 708.e1–708.e8. 6 indexed citations

Beyar‐Katz, Ofrat, Chava Perry, Efrat Luttwak, et al.. (2023). Response rates of extra‐nodal diffuse large B cell lymphoma to anti‐CD19‐CAR T cells: A real word retrospective multicenter study. European Journal Of Haematology. 111(1). 63–71. 4 indexed citations

Beyar‐Katz, Ofrat, et al.. (2023). Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?. Acta Haematologica. 147(1). 99–112. 3 indexed citations

Beyar‐Katz, Ofrat, et al.. (2023). CNS Prophylaxis in Diffuse Large B-Cell Lymphoma: A Common Toxic Clinical Practice Based on Abundant Opinion, Despite Evidence Suggesting Futility. Blood. 142(Supplement 1). 7260–7260. 1 indexed citations

Amit, Odelia, Liat Shargian, Ofrat Beyar‐Katz, et al.. (2023). Second Vs Third Line Treatment with Axicabtagene Ciloleucel for Large B Cell Lymphoma - a Real-Life National Multicenter Retrospective Cohort Study with Propensity Score Matching. Blood. 142(Supplement 1). 4886–4886. 1 indexed citations

Ram, Ron, Tal Freund, Tami Halperin, et al.. (2022). Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort Study. Transplantation and Cellular Therapy. 28(5). 278.e1–278.e4. 7 indexed citations

Cohen, Dan, Ofrat Beyar‐Katz, Einat Even‐Sapir, & Chava Perry. (2022). Lymphoma pseudoprogression observed on [18F]FDG PET-CT scan 15 days after CAR-T infusion. European Journal of Nuclear Medicine and Molecular Imaging. 49(7). 2447–2449. 10 indexed citations

Ram, Ron, Sigal Grisariu, Liat Shargian, et al.. (2021). A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study. Blood. 138(Supplement 1). 1733–1733.

10.

Cohen, Dan, Efrat Luttwak, Ofrat Beyar‐Katz, et al.. (2021). [18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies. European Journal of Nuclear Medicine and Molecular Imaging. 49(3). 953–962. 40 indexed citations

11.

Ram, Ron, David Hagin, Tal Freund, et al.. (2021). Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study. Transplantation and Cellular Therapy. 27(9). 788–794. 94 indexed citations

12.

Beyar‐Katz, Ofrat, Anat Reiner‐Benaim, Irit Avivi, et al.. (2019). Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy. Molecular Cancer Research. 17(11). 2331–2340. 30 indexed citations

13.

Beyar‐Katz, Ofrat, Noa Lavi, Israel Henig, et al.. (2019). Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation. Leukemia & lymphoma. 60(10). 2449–2456. 10 indexed citations

14.

Timaner, Michael, Madeleine Benguigui, Ofrat Beyar‐Katz, et al.. (2018). Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells. Cancer Research. 78(5). 1253–1265. 83 indexed citations

15.

Beyar‐Katz, Ofrat, et al.. (2017). The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 17(12). 863–869. 12 indexed citations

16.

Shaked, Yuval, Elizabeth Pham, Santosh Hariharan, et al.. (2016). Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy. Cancer Research. 76(20). 5983–5993. 43 indexed citations

17.

Zuckerman, Tsila, Ofrat Beyar‐Katz, & Jacob M. Rowe. (2016). Should autotransplantation in acute myeloid leukemia in first complete remission be revisited?. Current Opinion in Hematology. 23(2). 88–94. 10 indexed citations

18.

Ginsberg, Shira, Itzhak Rosner, Gleb Slobodin, et al.. (2016). Autoinflammatory associated vasculitis. Seminars in Arthritis and Rheumatism. 46(3). 367–371. 6 indexed citations

19.

Beyar‐Katz, Ofrat, Tsila Zuckerman, Riva Fineman, et al.. (2015). Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to Therapy. Biology of Blood and Marrow Transplantation. 22(6). 975–981. 23 indexed citations

20.

Beyar‐Katz, Ofrat & Yuval Shaked. (2014). Host effects contributing to cancer therapy resistance. Drug Resistance Updates. 19. 33–42. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact